Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000462450 | SCV000543210 | pathogenic | Benign neonatal seizures | 2023-05-15 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on KCNQ3 protein function. ClinVar contains an entry for this variant (Variation ID: 21417). This missense change has been observed in individuals with benign familial neonatal seizures (PMID: 18249525, 23146207). It has also been observed to segregate with disease in related individuals. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 330 of the KCNQ3 protein (p.Arg330Cys). |
Genome Diagnostics Laboratory, |
RCV000020602 | SCV000743523 | pathogenic | Seizures, benign familial neonatal, 2 | 2014-10-08 | criteria provided, single submitter | clinical testing | |
3billion | RCV000020602 | SCV002012197 | likely pathogenic | Seizures, benign familial neonatal, 2 | 2021-10-02 | criteria provided, single submitter | clinical testing | Same nucleotide change resulting in same amino acid change has been previously reported as pathogenic/likely pathogenic with strong evidence (PMID: 23146207, PS1). It is not observed in the gnomAD v2.1.1 dataset (PM2). In silico tool predictions suggest damaging effect of the variant on gene or gene product (REVEL: 0.973, 3Cnet: 0.981, PP3). Therefore, this variant is classified as likely pathogenic according to the recommendation of ACMG/AMP guideline. |
Gene |
RCV003233074 | SCV003931034 | pathogenic | not provided | 2022-12-05 | criteria provided, single submitter | clinical testing | Published functional studies demonstrate abnormal channel function (Miceli et al., 2015); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 23146207, 16883520, 28717674, 35627257, 34474328, 18249525, 25524373, 34136434) |
Gene |
RCV000020602 | SCV000041091 | not provided | Seizures, benign familial neonatal, 2 | no assertion provided | literature only | Same variant detected in 2 unrelated families | |
OMIM | RCV000020602 | SCV000121585 | pathogenic | Seizures, benign familial neonatal, 2 | 2013-05-01 | no assertion criteria provided | literature only | |
Diagnostic Laboratory, |
RCV000020602 | SCV000734592 | pathogenic | Seizures, benign familial neonatal, 2 | no assertion criteria provided | clinical testing |